Successful use of extracorporeal membrane oxygenation for life‐threatening macrophage activation syndrome after treatment with tocilizumab in an systemic juvenile idiopathic arthritis patient

• Autores principales: Xi Yang (Autor), Yingfu Chen (Autor), Rongxin Dai (Autor), Yunfei An (Autor), Xin Yan (Autor), Xiaodong Zhao (Autor), Xuemei Tang (Autor)
• Formato: Libro
• Publicado: Wiley, 2023-12-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Abstract Macrophage activation syndrome (MAS) is a rare, potentially life‐threatening condition in rheumatic diseases. The primary treatments consist of high‐dose corticosteroids and immunosuppressive drugs, although more recently, cytokine inhibitors like anakinra or tocilizumab (TCZ) have been rep...